Skip to Content
webinars

Blood-Based Cancer Testing: The Technological, Clinical, Policy, and Legislative Landscape

Dates:
Jun 5, 2025
Time:
1:00 pm EDT
Presented by Guardant Health
Register Now Registration takes place at a third-party website.

About This Webinar

The ability to detect cancer signals through a simple blood draw has revolutionized cancer care throughout the continuum, from screening to advanced cancer treatment selection. Though innovative, these tests are technologically complex and can be difficult for payers to manage. The genomic expertise and rapidly evolving evidence base present challenges for traditional payer frameworks and processes, despite having significant impacts on patient outcomes.

This webinar provides evidence-based overviews of the benefits, limitations, and opportunities for blood-based cancer testing. With scientific and policy expertise, we will highlight management strategies for payers interested in aligning with state legislation and best practice guidelines.

Attendees Will Learn About

  • The key challenges and opportunities in blood-based cancer testing for patients
  • How to evaluate different approaches for different clinical scenarios
  • Key legislation impacting coverage for these types of tests
  • How to partner with providers and laboratories to effectively manage these tests

Presenters

Julie Wiedower, MS, PhD, CGC

Senior Director of Medical Affairs

Guardant Health

As Senior Director of Medical Affairs for Guardant Health managed care team, Julie provides expert evidence review of tumor genomic and epigenomic profiling in cancer for health plan audiences. Her passion lies in speaking enthusiastically and effectively to multiple stakeholders while advocating for increased access to quality genetics care and forming partnerships between providers,…

Learn more about Julie Wiedower, MS, PhD, CGC